Grants

The National Institute of Allergy and Infectious Diseases, NIAID, part of the National Institutes of Health, NIH, has awarded $2.5 million in grants to support research on bacteriophage therapy, and Texas A&M AgriLife Research is among the grant recipients.

A multi-university team of researchers, led by Prashant Shenoy, distinguished professor in the University of Massachusetts Amherst's College of Information and Computer Sciences (CICS), will be tackling this challenge thanks to a $3 million grant jointly administered by the National Science Foundation and VMware, a private technology cloud-computing company.

Wei Xiong, assistant professor of mechanical engineering and materials science at the University of Pittsburgh Swanson School of Engineering, will study the fundamental mechanisms of alloys created by additive manufacturing. The new project that received a $526,334 Faculty Early Career Development (CAREER) Award from the National Science Foundation (NSF). The five-year project, titled "Unraveling Fundamental Mechanisms Governing Grain Refinement in Complex Concentrated Alloys Made by Additive Manufacturing Towards Strong and Ductile Structures," began on April 15, 2021.

COVID-19 vaccines are more available now than ever, so why is the number of people taking them so low in diverse communities across metropolitan Houston and beyond? The University of Houston's HEALTH Center for Addictions Research and Cancer Prevention is set to find out and to develop culturally responsive solutions.

From abandoned coal mines to shuttered factories, the Brownfields Assistance Center at West Virginia University has helped communities resurrect once lifeless properties since 2006. With a boost from the U.S. Environmental Protection Agency in the amount of $1 million, the Center will continue its mission to empower communities to transform brownfields -- property hindered from redevelopment or reuse due to the presence or perceived presence of a hazardous substance or contaminant.

New York University's Sonali Shukla McDermid has been named an Andrew Carnegie Fellow, one of 26 selected to the 2021 class.

Research collaboration will work to create next-generation of microbial therapies to replace donor-derived faecal microbiota transplantation (FMT). FMT is an established life-saving therapy for Clostridioides difficile infection and is emerging as a clinically beneficial treatment for other gut conditions. The new innovation would provide significant advantages to the cost and scale of FMT, which can currently only use material harvested from healthy human donors.